Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn InfantsColeen K. Cunningham, Karin Nielsen‐Saines, Edmund V. Capparelli et al.|The Journal of Infectious Diseases|2019Cited by 62
Nevirapine- Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy in HIV-Infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized TrialLinda Barlow‐Mosha, Konstantia Angelidou, Jane C. Lindsey et al.|Clinical Infectious Diseases|2016Cited by 43